[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE204476T1 - Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem - Google Patents

Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem

Info

Publication number
ATE204476T1
ATE204476T1 AT93904225T AT93904225T ATE204476T1 AT E204476 T1 ATE204476 T1 AT E204476T1 AT 93904225 T AT93904225 T AT 93904225T AT 93904225 T AT93904225 T AT 93904225T AT E204476 T1 ATE204476 T1 AT E204476T1
Authority
AT
Austria
Prior art keywords
dichlorophenyl
diamino
triazi
edema
medication
Prior art date
Application number
AT93904225T
Other languages
English (en)
Inventor
Meire Nakamura-Craig
Michael John Leach
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE204476T1 publication Critical patent/ATE204476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT93904225T 1992-02-19 1993-02-18 Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem ATE204476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203483A GB9203483D0 (en) 1992-02-19 1992-02-19 Anti-inflammatory compounds
PCT/GB1993/000341 WO1993016700A1 (en) 1992-02-19 1993-02-18 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and ×dema

Publications (1)

Publication Number Publication Date
ATE204476T1 true ATE204476T1 (de) 2001-09-15

Family

ID=10710643

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93904225T ATE204476T1 (de) 1992-02-19 1993-02-18 Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem

Country Status (18)

Country Link
US (1) US5712277A (de)
EP (1) EP0626851B1 (de)
KR (1) KR950700067A (de)
AT (1) ATE204476T1 (de)
AU (1) AU684711B2 (de)
CA (1) CA2129043C (de)
CY (1) CY2299B1 (de)
DE (1) DE69330638T2 (de)
DK (1) DK0626851T3 (de)
ES (1) ES2162813T3 (de)
GB (2) GB9203483D0 (de)
GR (1) GR3036958T3 (de)
IL (1) IL104775A (de)
MX (1) MX9300927A (de)
NZ (1) NZ249197A (de)
PT (1) PT626851E (de)
TW (1) TW226331B (de)
WO (1) WO1993016700A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
DE69527153T2 (de) * 1994-12-30 2002-12-19 The Wellcome Foundation Ltd., Greenford Verfahren zur herstellung von lamotrigine
GB9625795D0 (en) * 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
EP1423168B1 (de) 2001-09-03 2006-02-08 Newron Pharmaceuticals S.p.A. Pharmazeutische zusammensetzung mit gabapentin oder deren analog und einem alpha-aminoamid und analgetische verwendung dieser zusammensetzung
ME01801B (me) * 2004-09-10 2011-02-28 Newron Pharm Spa UPOTREBA (R)-(HALOBENZILOKSI) BENZILAMINO-PROPANAMIDA KAO SELEKTIVNIH MODULATORA NATRIJUMOVIH l/ILI KALCIJUMOVIH KANALA
CN107921046B (zh) * 2015-06-12 2022-10-14 格林威治大学 作为干扰素-γ抑制剂的三嗪衍生物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
US4310551A (en) * 1979-03-19 1982-01-12 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
EP0626851A1 (de) 1994-12-07
AU3509293A (en) 1993-09-13
WO1993016700A1 (en) 1993-09-02
EP0626851B1 (de) 2001-08-22
AU684711B2 (en) 1998-01-08
TW226331B (de) 1994-07-11
GR3036958T3 (en) 2002-01-31
GB2277265A (en) 1994-10-26
IL104775A0 (en) 1993-06-10
US5712277A (en) 1998-01-27
DK0626851T3 (da) 2001-12-03
GB9203483D0 (en) 1992-04-08
ES2162813T3 (es) 2002-01-16
GB2277265B (en) 1996-01-10
DE69330638D1 (de) 2001-09-27
JPH07503968A (ja) 1995-04-27
MX9300927A (es) 1994-08-31
GB9414348D0 (en) 1994-09-07
CA2129043C (en) 2004-01-27
CY2299B1 (en) 2003-07-04
IL104775A (en) 1997-02-18
JP3713271B2 (ja) 2005-11-09
KR950700067A (ko) 1995-01-16
PT626851E (pt) 2002-02-28
NZ249197A (en) 1997-05-26
CA2129043A1 (en) 1993-09-02
DE69330638T2 (de) 2002-06-27

Similar Documents

Publication Publication Date Title
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE211384T1 (de) Verwendung von adenosinantagonisten zur vorbeugung und behandlung von pankreatitis und ulcera
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
DE69304843D1 (de) Methode zur Behandlung von Haarausfall
ATE294584T1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE254919T1 (de) Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
DK0836853T3 (da) Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
ATE147980T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triaz nisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
DE69116452D1 (de) Verwendung von 3-Oxygermylpropionsäure zur Behandlung des Erkältungssyndroms

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee